Tradestie Institutional Equity Comparison Engine

PMI vs DCTH โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

DCTH Overall Edge

DCTH Captures Institutional Edge (4โ€“0 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Delcath Systems Inc (DCTH) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, PMI trades at N/M Forward P/E with -248.1% operating margin (+38.6% YoY revenue) versus DCTH at 70.3x Forward P/E and 5.2% operating margin (+70.7% YoY). In options structure, PMI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against DCTH sits in BREAKOUT (29th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner DCTH
PMI N/M vs DCTH 70.3x Fwd P/E
Growth & Margin Winner DCTH
Op Margin -248.1% vs 5.2% ยท YoY +38.6% vs +70.7%
Momentum & Technical Winner DCTH
1Y +107.2% vs +122.4% ยท 52W Pos 34% vs 77%
Options & Structure Winner DCTH
UNCLASSIFIED (N/A IV) vs BREAKOUT (29th %ile IV)
PMI NYSE American
Picard Medical, Inc.
Surgical & Medical Instruments & Apparatus
$6.30
-2.17% 1D
Market Cap $17.1M
1M Return -34.58%
1Y Return +107.24%
Forward P/E N/M
Unified AI Score
48.4 / 100 HOLD
Tech 39.0 Fund 45.0 Flow 50.0 Mom 50.0
DCTH NASDAQ
Delcath Systems Inc
Surgical & Medical Instruments & Apparatus
$19.24
-2.34% 1D
Market Cap $685.3M
1M Return +30.88%
1Y Return +122.43%
Forward P/E 70.3x
Unified AI Score
35.4 / 100 SELL
Tech 50.0 Fund 36.0 Flow 73.0 Mom 44.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: PMI +107.24% DCTH +122.43% Spread: +25.6 pp (PMI Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period PMI Revenue DCTH Revenue PMI Op. Margin DCTH Op. Margin Margin Edge
FY2013 N/A $0M N/A -4179.6% DCTH
FY2014 N/A $0M N/A -1805.8% DCTH
FY2015 N/A $0M N/A -870.6% DCTH
FY2021 N/A $0M N/A -690.0% DCTH
FY2022 N/A $0M N/A -1245.1% DCTH
FY2023 N/A $0M N/A -1849.0% DCTH
FY2024 $0M $40M -312.3% -33.4% DCTH
FY2025 $0M $90M -268.4% 0.8% DCTH

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: PMI (2) vs DCTH (8)
Institutional Metric PMI DCTH Criterion Row Winner
Market Capitalization Scale $17.1M $685.3M Larger Scale DCTH
Trailing P/E Ratio Valuation 2.9x 123.1x Lower Multiple PMI
Forward P/E Ratio Valuation N/M 70.3x Lower Multiple DCTH
Revenue Growth (YoY) Growth +38.6% +70.7% Higher Growth DCTH
Operating Margin (TTM) Profitability -248.1% 5.2% Higher Margin DCTH
Net Profit Margin Profitability 0.0% 6.0% Higher Margin DCTH
Return on Equity (ROE) Capital Efficiency 0.0% 5.4% Higher ROE DCTH
52-Week Range Position Momentum 34% ($0โ€“$18) 77% ($8โ€“$23) Stronger Trend DCTH
Beta / 30D Volatility Risk Regime 54.06ฮฒ ยท 134% Vol 1.64ฮฒ ยท 130% Vol Lower Realized Risk DCTH
Unified Institutional Score Composite Signal 48.4 / 100 (HOLD) 35.4 / 100 (SELL) Higher Composite PMI

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full PMI vs DCTH Buy Guide
PMI UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PMI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
DCTH BREAKOUT
69d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 29th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live DCTH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither PMI nor DCTH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.